This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Array BioPharma Inc
ARRY : NASDAQ : Health Care
$3.75 0.11 | 3.02%
Today's Range: 3.51 - 3.76
Avg. Daily Volume: 1,458,200
09/15/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
ARRY ARRAY BIOPHARMA INC 3.69 486.43 n/m 42.08 -39.53
FOLD AMICUS THERAPEUTICS INC 7.04 554.06 n/m 1.29 n/a
OMED ONCOMED PHARMACEUTICALS 18.28 544.03 n/m 43.95 113.98
AMAG AMAG PHARMACEUTICALS INC 24.60 540.17 n/m 88.96 16.42
HPTX HYPERION THERAPEUTICS INC 26.17 539.05 29.08 90.69 1021.32
XOMA XOMA CORP 4.85 518.46 n/m 28.23 -9.66
OSIR OSIRIS THERAPEUTICS INC 13.34 457.70 n/m 38.31 165.42
SNSS SUNESIS PHARMACEUTICALS INC 7.45 450.30 n/m 7.96 27.75
TKMR TEKMIRA PHARMACEUTICALS CORP 19.85 438.80 n/m 16.81 39.51
VNDA VANDA PHARMACEUTICALS INC 12.53 424.49 n/m 37.50 15.03
CTIC CTI BIOPHARMA CORP 2.67 400.32 n/m 36.00 2413.96
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARRY Ind Avg S&P 500
n/m 86.69 19.81

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs